CRONOS GROUP INC. Cash and Cash Equivalents, Fair Value Disclosure
CRONOS GROUP INC. (CRON) had Cash and Cash Equivalents, Fair Value Disclosure of $791.79 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-02-26
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $791.79M.
- 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure $858.80M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $791.79M 10-K · filed 2026-02-26 |
| 2024-12-31 | $858.80M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |